Stemson is going to use minipigs in the next stage of their hair cloning research
- Thread starter werefckd
- Start date
Yep, but they have too much pride to.
- Reaction score
- 1,104
Yep, they even call their whole project like this: people can truly cure their hairloss with Stemson Therapeutics.
It would make a huge damage in their reputation if they would miserably fail.
Because of that I think they wont leave the project, but much rather continue on it to enhance it. Which means + 5-10 years for the "cure" LMFAOOO.
- Reaction score
- 1,104
I hear people saying that Stemson's approach will be able to create embrionic follicles, but actually, they use YOUR cells, which are def. NOT embrionic. So how is that even possible. I can't find any document or paper to proof that, in relation to their technology.
If they do ARE embrionic, this will literally be a cure to male pattern baldness, because follicles get sensitive within age and if they are "newly born", they won't get to androgens exposed.
-> Every 15 years, the same procedure
If they do ARE embrionic, this will literally be a cure to male pattern baldness, because follicles get sensitive within age and if they are "newly born", they won't get to androgens exposed.
-> Every 15 years, the same procedure
No idea. I thought originally they wanted to start in H1 2021 but I guess covid ruined that. 12-18 months seems like a good guess, but you'd be looking at a very small phase 1 trial for safety purposes.
- Reaction score
- 292
They just filled their histologist position and removed the opening from their website
- Reaction score
- 1,104
So they are ready for pre clinical trials?! Lol
- Reaction score
- 292
I don’t think yet. Nobody knows when they will start. They didn’t announce completion of series A funding
- Reaction score
- 1,104
They would need more investors. They just have half of their planned funding mh
- Reaction score
- 292
This is always the step where research for alopecia stops because people don’t care about this disease. Hopefully they can find the money to continue
- Reaction score
- 292
Not even for phase 1. This is still only for preclinical studies
“After closing a $7.5M seed financing led by Allergan Plc, a division of Abbvie, and Fortunis Capital, Stemson is raising $15M in a Series A to fund product optimization in a pig skin model, which is expected to be our preclinical model to produce data for our first-in-human trial application. The funds will support development of the scaffold component, expansion and optimization of the cell production protocol, and multiple cycles of pig studies.”
Thanks for quote and the reference. It seems I missed that one and yes you are right.
So yeah it seems they are basically a year away from clinical. Preclinical trials usually last 6 months but the funding is the much more needed component
Man we wouldn't be in this if Tsuji or Hewitt were actually doing something. I hope Stemson does their clinical trials in UK better chance for faster approval.
So yeah it seems they are basically a year away from clinical. Preclinical trials usually last 6 months but the funding is the much more needed component
Man we wouldn't be in this if Tsuji or Hewitt were actually doing something. I hope Stemson does their clinical trials in UK better chance for faster approval.
- Reaction score
- 292
Do you know the difference in the terminology they use. what is different between seed round vs series A is that different? they will spend all this year to find the funding just for pre clinical.
these are the definitions I found:
Seed Round: Refers to a series of related investments in which 15 or less investors "seed" a new company with anywhere from $50,000 to $2 million. This money is often used to support initial market research and early product development. Investors are typically rewarded with convertible notes, equity, or a preferred stock option in exchange for their investment.
Series A: Refers to a smaller number of angel investors or VCs who contribute an average of $2-10 million in exchange for equity. The fund is named after the type of equity investors hope to eventually receive: Series A Preferred shares. This implies they will be the first group of investors to receive preferred shares.
Maybe if they are tying to raise capital from fortunis or other investors they need to work out business details before proceeding. So it’s expected to take some time at least
Last edited:
The fact they opened a position for a histotechnician means something. What's the point of doing it if they plan to spend one year raising funds? I think they are closer to preclinicals than we might think, but again, only time and announcements will tell.
No they don't have half yet, the $7.5M is for their seed funding and according to them they now need another $15M to for series A funding for preclinicals.
Nice find, any progress with Stemson is amazing news.
They're funded by Allergan. If this method shows promise/ is legitimate they will basically have unlimited funding when it's all said and done.
I wonder whether this will continue to hold true as they become more impacted by their acquisition. Allergan has been fairly committed to finding a cure for hair loss but I haven't been able to find much about AbbVie, their new parent company.
And considering they didn't even give Stemson $7.5M (Fortunis chipped in for that too) it comes off as though they have some reservations about just dumping money into a cure.
Last edited:
- Reaction score
- 1,104
Oh well... same story again... nobody wants to fund Stemson. A shame they have to waste a year for finding investors instead of continuing research. All great breakthroughs in this field get abandoned because of financial conditions, no support, no funding.